• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$51.99 -$0.26 (-0.50%)

REAL-TIME: Last trade at

Baxter International, Inc.

NYSE:BAX

Supply Your Portfolio With Healthy Growth From Medical Suppliers

7 Health-Care Dividend Stocks With Encouraging Accounts Receivable Trends

Has Momenta Pharmaceuticals Become the Perfect Stock?

Becton Dickinson Remains Neutral - Analyst Blog

Baxter Remains Neutral - Analyst Blog

Is the Sky the Limit for ICU Medical?

Becton Beats Rev Est, Tweaks Guidance - Analyst Blog

Baxter Completes Purchase Of SIGMA International For $90 Million

Applications Given Early Antitrust Clearance

Stocks to watch Thursday: DuPont, Great Wolf

UPDATE: Baxter Profit Up On Demand For Blood, Immune Therapies

Baxter Beats 1Q Forecasts - Analyst Blog

Baxter International Beats on Revenue and Matches Expectations on EPS

Why Baxter International May Be About to Take Off

Earnings Preview: Baxter - Analyst Blog

UPDATE: FDA Seeks Added Info On Baxter, Halozyme HyQ Therapy

US HOT STOCK FUTURES: HOT STOCKS TO WATCH

Becton to Sell Discovery Labware - Analyst Blog

Why Halozyme Shares Got Crushed

Is Halozyme the Perfect Stock?

Why Did These Stocks Just Die?

Health-Care Sector's Paltry Insurance Against Risk of Change

Will Baxter International Help You Retire Rich?

Reaffirming Becton at Neutral - Analyst Blog

Reaffirming Baxter at Neutral - Analyst Blog

Baxter Wins Marketing Rights in EU - Analyst Blog

Haemonetics Reaffirmed at Neutral - Analyst Blog

Earnings Scorecard: Becton - Analyst Blog

Obama Accelerates Race for Alzheimer's Cure

Stocks on the Road to Greatness

A Multibillion-Dollar Market Filled With Unknowns

All Good Things Must Come to an End

Becton Beats, Profit Drops - Analyst Blog

Earnings Scorecard: Baxter - Analyst Blog

Earnings Preview: Becton, Dickinson - Analyst Blog

What Baxter International Does With Its Cash

Golf Clap for Baxter International

US STOCK FUTURES: HOT STOCKS TO WATCH

UPDATE: Baxter 4Q Profit Up 9.5% On Revenue Growth; Earnings Views Weak

Baxter Beats Estimates - Analyst Blog

See More Articles...